• Profile
Close

Outcome of 490 desensitizations to chemotherapy drugs with a rapid one-solution protocol

The Journal of Allergy and Clinical Immunology: In Practice Jan 24, 2018

Pérez-Rodriguez E, et al. - Desensitization for chemotherapy drugs has become an option to maintain first-line therapy in patients who have suffered hypersensitivity reactions to chemotherapy drugs. Researchers carried out a prospective observational study to report their experience in desensitization with antineoplastic agents using a rapid 1-solution protocol. They found that 1-solution protocol was safe and useful, particularly for mild-to-moderate reactions and nonplatinum drugs.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay